Puff or pass? The truth about vaping, marijuana, and tobacco safety
Abstract
Background:
Cannabis and electronic cigarettes (EC) are often perceived as safer than combustible tobacco, yet contemporary evidence shows important pulmonary risks. Cannabis use has shifted toward high-potency products and aerosolized delivery (vaping, dabbing).
Methods:
We performed a targeted narrative review of PubMed/MEDLINE, Web of Science, Scopus, and the Cochrane Library, supplemented by manual reference review, emphasizing English-language studies relevant to pulmonary outcomes of cannabis, electronic cigarettes, and tobacco.
Results:
Although acute bronchodilation is described, chronic use is linked to respiratory symptoms and airway injury, and rare complications (e.g., bullous disease). In large cohorts of older smokers, moderate marijuana use was not clearly associated with accelerated chronic
obstructive pulmonary disease (COPD) progression; however, heavy lifetime exposure may increase chronic bronchitis symptoms. EC aerosols contain nicotine and/or Δ
9
-tetrahydrocannabinol, solvents, metals, and flavorants; menthol increases inhaled particle counts and associates
with worse spirometry. The 2019 EC or vaping-associated lung injury (EVALI) outbreak, strongly linked to vitamin E acetate contamination and underscores the hazards of illicit and/or poorly regulated products. In two studies of long smoking histories, EC use correlated with chronic bronchitis
and did not improve cessation; however, more recent evidence from multiple randomized controlled trials and…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.